Peptide Schedule Research TeamReviewed Apr 20267 Citations
Calcitonin (Miacalcin)32 residuesCSNLSTCVLGKLSQELHKLQTYPRTNTGSGTPEach bubble = one amino acid. Size = residue mass. Color = chemical class.Adjust vial, water, and dose — answer updates live
on a U-100 syringe for a 50mcg dose
Never miss a dose — 50mcg daily, draw 0.00 units on U-100 syringe.
No signup required to use calculator
Sync to any calendar app
Calcitonin (Miacalcin) is an FDA-approved 32-amino-acid peptide that inhibits bone resorption. Positioned as last-line for osteoporosis, its real strength is acute bone pain relief and rapid serum calcium reduction in emergencies. Available in nasal spray and subcutaneous injection formulations.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 50 IU | Daily |
| Moderate | 100 IU | Daily |
| Aggressive | 200 IU | Daily |
Calcitonin-salmon injection comes as a pre-filled solution at 200 IU/mL. No reconstitution, no bacteriostatic water, no mixing math. The standard therapeutic dose is 100 IU, which is 0.5 mL from the vial (draw to 50 units on a U-100 insulin syringe). Do the skin test first. This isn't optional. Dilute to 10 IU/mL with normal saline, inject 0.1 mL intracutaneously on the inner forearm, wait 15 minutes. Any wheal or redness means you don't proceed. Evening dosing reduces nausea. Let the vial sit out of the fridge for 15 to 30 minutes before injecting; cold solution makes flushing worse. Rotate injection sites between the abdomen, outer thigh, and upper arm. Co-supplementation is not optional either: at least 1000 mg/day calcium and 400 IU/day vitamin D throughout therapy. Without it, the risk of hypocalcemia goes up meaningfully. Store unopened vials at 2 to 8 degrees C. Once opened, use within 14 days.
Dosing based on Miacalcin (calcitonin-salmon) FDA Prescribing Information (2017) — 9 published references.View all sources →
Cross-check your Calcitonin (Miacalcin) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
